journal article·2023-05-14Open access

Cellular Alterations in Carbohydrate and Lipid Metabolism Due to Interactions with Nanomaterials

Ana Martín-Pardillos, Pilar Martin-Duque

Abstract

Nanoparticles (NPs) have unique physicochemical properties that are useful for a broad range of biomedical and industrial applications; nevertheless, increasing concern exists about their biosafety. This review aims to focus on the implications of nanoparticles in cellular metabolism and their outcomes. In particular, some NPs have the ability to modify glucose and lipid metabolism, and this feature is especially interesting to treat diabetes and obesity and to target cancer cells. However, the lack of specificity to reach target cells and the toxicological evaluation of nontargeted cells can potentially induce detrimental side effects, closely related to inflammation and oxidative stress. Therefore, identifying the metabolic alterations caused by NPs, independent of their application, is highly needed. To our knowledge, this increase would lead to the improvement and safer use with a reduced toxicity, increasing the number of available NPs for diagnosis and treatment of human diseases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Vitamin C and Antioxidants Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, 50009 Zaragoza, Spain

Department of Chemical Engineering and Environmental Technology (IQTMA), University of Zaragoza, 50018 Zaragoza, Spain

Instituto de Investigaciones Sanitarias de Aragón (IIS Aragón), 50009 Zaragoza, Spain

Ciber Bioingeniería y Biomateriales (CIBER-BBN), Instituto de Salud Carlos lll, 28029 Madrid, Spain

Surgery Department, Medicine Medical School, University of Zaragoza, 50009 Zaragoza, Spain

Funding

European Research Council · Instituto de Salud Carlos III · Fondo Europeo de Desarrollo Regional

References (100+)

Show source-provided references
1. Review on nanoparticles and nanostructured materials: History, sources, toxicity and regulations10.3762/bjnano.9.98 ↗
2. Long-Term Effects of Nanoparticles on Nutrition and Metabolism10.1002/smll.201303635 ↗
3. Toxicity of inorganic nanomaterials in biomedical imaging10.1016/j.biotechadv.2013.12.009 ↗
4. Nanomaterials and nanoparticles: Sources and toxicity10.1116/1.2815690 ↗
5. Nanomaterial and Nanoparticle: Origin and Activity10.1007/978-3-319-46835-8_3 ↗
6. Griffin, S., Masood, M.I., Nasim, M.J., Sarfraz, M., Ebokaiwe, A.P., Schäfer, K.-H., Keck, C.M., and Jacob, C. (2017). Natural Nanoparticles: A Particular Matter Inspired by Nature. Antioxidants, 7.10.3390/antiox7010003 ↗
7. Multifunctional Mesoporous Silica Nanocomposite Nanoparticles for Theranostic Applications10.1021/ar2000259 ↗
8. Jana, N.R., and Ray, S.C. (2015). Applications of Graphene and Graphene-Oxide Based Nanomaterials Micro and Nano Technologies, Elsevier.
9. Nanoparticles as potential clinical therapeutic agents in Alzheimer’s disease: Focus on selenium nanoparticles10.1080/17512433.2017.1324781 ↗
10. The versatile biomedical applications of bismuth-based nanoparticles and composites: Therapeutic, diagnostic, biosensing, and regenerative properties10.1039/C9CS00283A ↗
11. Nanostructured Materials: State of the Art and Perspectives10.1016/0965-9773(95)00025-9 ↗
12. Classification of nanostructures by dimensionality and concept of surface forms engineering in nanomaterial science10.1016/j.msec.2006.09.023 ↗
13. Zero-dimensional, one-dimensional, two-dimensional and three-dimensional nanostructured materials for advanced electrochemical energy devices10.1016/j.pmatsci.2011.08.003 ↗
14. Biomedical applications of nanotechnology10.1007/s12551-016-0246-2 ↗
15. Pacheco-Blandino, I., Vanner, R., and Buzea, C. (2012). Toxicity of nanoparticles. Toxic. Build. Mater., 427–475.10.1533/9780857096357.427 ↗
16. Ray, S.C., and Jana, N.R. (2017). Carbon Nanomaterials for Biological and Medical Applications Micro and Nano Technologies, Elsevier.
17. Synthesis of Organic Nanoparticles and their Applications in Drug Delivery and Food Nanotechnology: A Review
18. Composite nanoparticles for gene delivery10.1016/B978-0-12-800148-6.00005-5 ↗
19. The surface properties of nanoparticles determine the agglomeration state and the size of the particles under physiological conditions10.3762/bjnano.5.188 ↗
20. Stable nanoparticle aggregates/agglomerates of different sizes and the effect of their size on hemolytic cytotoxicity10.3109/17435390.2010.536615 ↗
21. Nanoparticles in the clinic: An update10.1002/btm2.10143 ↗
22. Gold nanoparticles (GNPs) in biomedical and clinical applications: A review10.1002/nano.202100255 ↗
23. Superparamagnetic Iron Oxide Nanoparticles: Cytotoxicity, Metabolism, and Cellular Behavior in Biomedicine Applications10.2147/IJN.S321984 ↗
24. Supramolecular organic nanotubes for drug delivery10.1016/j.mtadv.2022.100239 ↗
25. Liposome-based nanocapsules for the controlled release of dietary curcumin: PDDA and silica nanoparticle-coated DMPC liposomes enhance the fluorescence efficiency and anticancer activity of curcumin10.1039/D2RA00071G ↗
26. Polymer-capped gold nanoparticles as nanozymes with improved catalytic activity for the monitoring of serum ciprofloxacin10.1039/D2AN00158F ↗
27. Brief Outlook on Polymeric Nanoparticles, Micelles, Niosomes, Hydrogels and Liposomes: Preparative Methods and Action
28. Baetke, S.C., Lammers, T., and Kiessling, F. (2015). Applications of nanoparticles for diagnosis and therapy of cancer. Br. J. Radiol., 88.10.1259/bjr.20150207 ↗
29. Strategies in the design of nanoparticles for therapeutic applications10.1038/nrd2591 ↗
30. Role of nanoparticle size, shape and surface chemistry in oral drug delivery10.1016/j.jconrel.2016.07.051 ↗
31. Shape-dependent internalization kinetics of nanoparticles by membranes10.1039/C5SM01869B ↗
32. Anchored but not internalized: Shape dependent endocytosis of nanodiamond10.1038/srep46462 ↗
33. The impact of nanoparticle shape on cellular internalisation and transport: What do the different analysis methods tell us?10.1039/C9MH00664H ↗
34. Gemcitabine cationic polymeric nanoparticles against ovarian cancer: Formulation, characterization, and targeted drug delivery10.1080/10717544.2022.2058645 ↗
35. Understanding and overcoming major barriers in cancer nanomedicine10.2217/nnm.10.23 ↗
36. Nanoparticle protein corona evolution: From biological impact to biomarker discovery10.1039/D1NR06580G ↗
37. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery10.1016/j.addr.2015.09.012 ↗
38. To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives10.1016/j.addr.2021.114079 ↗
39. The Use of Lactose as an Alternative Coating for Nanoparticles10.1016/j.xphs.2020.01.019 ↗
40. Chitosan mediated solid lipid nanoparticles for enhanced liver delivery of zedoary turmeric oil in vivo10.1016/j.ijbiomac.2020.01.222 ↗
41. Wang, W., Meng, Q., Li, Q., Liu, J., Zhou, M., Jin, Z., and Zhao, K. (2020). Chitosan Derivatives and Their Application in Biomedicine. Int. J. Mol. Sci., 21.10.3390/ijms21020487 ↗
42. Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization10.1038/srep02534 ↗
43. Nanoparticle-Based Diagnosis and Therapy10.2174/138945006777435245 ↗
44. Polymer functionalized gold nanoparticles as nonviral gene delivery reagents10.1002/jgm.2964 ↗
45. Nanoparticles for detection and diagnosis10.1016/j.addr.2009.11.004 ↗
46. Could nanoparticle corona characterization help for biological consequence prediction?10.1186/s12645-014-0007-5 ↗
47. Cooper, G.M. (2022, February 03). The Cell: A Molecular Approach, Available online: https://www.ncbi.nlm.nih.gov/books/NBK9879/.10.1093/hesc/9780197583746.001.0001 ↗
48. Clues from cell metabolism10.1038/465562a ↗
49. (2022, May 19). Nature. Cell Origins and Metabolism. Editor(s): Gary Coté, Mario De Tullio. Available online: https://www.nature.com/scitable/topic/cell-origins-and-metabolism-14122694/.
50. On the origin of cancer cells10.1126/science.123.3191.309 ↗
51. The Warburg effect: 80 years on10.1042/BST20160094 ↗
52. Nanosilver Incurs an Adaptive Shunt of Energy Metabolism Mode to Glycolysis in Tumor and Nontumor Cells10.1021/nn500719m ↗
53. Crucial role of the pentose phosphate pathway in malignant tumors (Review)
54. Selenium nanoparticles reduce glucose metabolism and promote apoptosis of glioma cells through reactive oxygen species-dependent manner10.1097/WNR.0000000000001386 ↗
55. Sedentary behavior and altered metabolic activity by AgNPs ingestion in Drosophila melanogaster10.1038/s41598-017-15645-6 ↗
56. Silver nanoparticles affect glucose metabolism in hepatoma cells through production of reactive oxygen species
57. Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes10.1126/science.275.5297.218 ↗
58. Resveratrol Suppresses Cancer Cell Glucose Uptake by Targeting Reactive Oxygen Species–Mediated Hypoxia-Inducible Factor-1α Activation10.2967/jnumed.112.115436 ↗
59. Enhanced growth inhibition effect of Resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels10.1016/j.colsurfb.2009.03.010 ↗
60. Poly(Ethylene Glycol)–Polylactide Micelles for Cancer Therapy10.3389/fphar.2018.00202 ↗
61. Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes10.1016/j.ijpharm.2011.01.056 ↗
62. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability
63. Regulation of cancer cell metabolism10.1038/nrc2981 ↗
64. A glucose-depleting silica nanosystem for increasing reactive oxygen species and scavenging glutathione in cancer therapy10.1039/C9CC06043J ↗
65. Surface-modified cobalt oxide nanoparticles: New opportunities for anti-cancer drug development10.1007/s12645-012-0026-z ↗
66. Effect of CoO nanoparticles on the carbohydrate metabolism of the brain of mice ‘‘Mus musculus”10.1016/j.jobaz.2015.12.003 ↗
67. Antidiabetic Activity of Zinc Oxide and Silver Nanoparticles on Streptozotocin-Induced Diabetic Rats10.3390/ijms15022015 ↗
68. Effect of Nano-magnesium Oxide on Glucose Concentration and Lipid Profile in Diabetic Laboratory Mice
69. Zinc oxide nanoparticles show antidiabetic activity in streptozotocin-induced Type 1 and 2 diabetic rats10.2217/nnm.12.205 ↗
70. Zinc oxide nanoparticles and a standard antidiabetic drug restore the function and structure of beta cells in Type-2 diabetes10.1016/j.biopha.2016.09.068 ↗
71. Jakaria Biological efficacy of zinc oxide nanoparticles against diabetes: A preliminary study conducted in mice10.1042/BSR20193972 ↗
72. Lipid nanoparticle delivery of glucagon receptor siRNA improves glucose homeostasis in mouse models of diabetes10.1016/j.molmet.2017.06.012 ↗
73. Matias, L.L.R., Costa, R.O.A., Passos, T.S., Queiroz, J.L.C., Serquiz, A.C., Maciel, B.L.L., Santos, P.P.A., Camillo, C.S., Gonçalves, C., and Amado, I.R. (2019). Tamarind Trypsin Inhibitor in Chitosan–Whey Protein Nanoparticles Reduces Fasting Blood Glucose Levels without Compromising Insulinemia: A Preclinical Study. Nutrients, 11.10.3390/nu11112770 ↗
74. Titanium Dioxide Nanoparticles in Food and Personal Care Products10.1021/es204168d ↗
75. Interaction of titanium dioxide nanoparticles with glucose on young rats after oral administration10.1016/j.nano.2015.06.002 ↗
76. RNA sequencing analysis shows that titanium dioxide nanoparticles induce endoplasmic reticulum stress, which has a central role in mediating plasma glucose in mice10.1080/17435390.2018.1446560 ↗
77. A mechanistic study to increase understanding of titanium dioxide nanoparticles-increased plasma glucose in mice10.1016/j.fct.2016.07.010 ↗
78. Nanosized Particles of Silica and Its Derivatives for Applications in Various Branches of Food and Nutrition Sectors10.1155/2015/852394 ↗
79. Vallet-Regi, M., Colilla, M., Izquierdo-Barba, I., and Manzano, M. (2017). Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights. Molecules, 23.10.3390/molecules23010047 ↗
80. Silicon dioxide nanoparticles induce insulin resistance through endoplasmic reticulum stress and generation of reactive oxygen species10.1186/s12989-019-0327-z ↗
81. Silica-coated magnetic nanoparticles induce glucose metabolic dysfunction in vitro via the generation of reactive oxygen species10.1007/s00204-019-02402-z ↗
82. Silica nanomaterials induce organ injuries by Ca2+-ROS-initiated disruption of the endothelial barrier and triggering intravascular coagulation10.1186/s12989-020-00340-8 ↗
83. Molecular mechanisms underlying zinc oxide nanoparticle induced insulin resistance in mice10.1080/17435390.2019.1663288 ↗
84. Robin, J. (2022). Anatomy and Physiology, OpenStax. BCcampus Open Education. Available online: https://opentextbc.ca/anatomyandphysiology/front-matter/preface-2/.
85. Nanotechnology advances towards development of targeted-treatment for obesity10.1186/s12951-019-0554-3 ↗
86. Gold nanoparticles: Preparation, properties, and applications in bionanotechnology10.1039/C1NR11188D ↗
87. Chen, H., Dorrigan, A., Saad, S., Hare, D.J., Cortie, M.B., and Valenzuela, S.M. (2013). In Vivo Study of Spherical Gold Nanoparticles: Inflammatory Effects and Distribution in Mice. PLoS ONE, 8.10.1371/journal.pone.0058208 ↗
88. Gold nanoparticles improve metabolic profile of mice fed a high-fat diet10.1186/s12951-018-0338-1 ↗
89. Gold nanoparticles as cell regulators: Beneficial effects of gold nanoparticles on the metabolic profile of mice with pre-existing obesity10.1186/s12951-018-0414-6 ↗
90. Gold nanoparticles synthesized with Smilax glabra rhizome modulates the anti-obesity parameters in high-fat diet and streptozotocin induced obese diabetes rat model10.1016/j.jphotobiol.2019.111643 ↗
91. Obesity is associated with macrophage accumulation in adipose tissue10.1172/JCI200319246 ↗
92. Self-assembled hyaluronic acid nanoparticles: Implications as a nanomedicine for treatment of type 2 diabetes10.1016/j.jconrel.2018.04.006 ↗
93. Self-assembled hyaluronic acid nanoparticle suppresses fat accumulation via CD44 in diet-induced obese mice10.1016/j.carbpol.2020.116161 ↗
94. Mesenchymal stem cells in health and disease10.1038/nri2395 ↗
95. Mesenchymal stem cell perspective: Cell biology to clinical progress10.1038/s41536-019-0083-6 ↗
96. Dynamics of Transcription Factors in Three Early Phases of Osteogenic, Adipogenic, and Chondrogenic Differentiation Determining the Fate of Bone Marrow Mesenchymal Stem Cells in Rats10.3389/fcell.2021.768316 ↗
97. Gold Nanoparticles Promote Osteogenic Differentiation of Mesenchymal Stem Cells through p38 MAPK Pathway10.1021/nn101373r ↗
98. Inhibition of Proliferation and Differentiation of Mesenchymal Stem Cells by Carboxylated Carbon Nanotubes10.1021/nn901479w ↗
99. Proteasome alterations during adipose differentiation and aging: Links to impaired adipocyte differentiation and development of oxidative stress10.1016/j.freeradbiomed.2011.08.001 ↗
100. Nanoparticles can induce changes in the intracellular metabolism of lipids without compromising cellular viability10.1111/j.1742-4658.2009.07324.x ↗